Resultados a largo plazo en pacientes manejadas sólo con biopsia de ganglio linfático centinela

Bibliografía
1. Fisher B, Bauer M, Wickerham DL,  et al.  Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer: an NSABP update.  Cancer. 1983;52(9):1551-1557
2. Krag DN, Anderson SJ, Julian TB,  et al.  Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.  Lancet Oncol. 2010;11(10):927-933
3. Veronesi U, Viale G, Paganelli G,  et al.  Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study.  Ann Surg. 2010;251(4):595-600
4. Fougo JL, Dinis-Ribeiro M, Araújo C,  et al.  Impact of lymphadenectomy on axillary recurrence and morbidity of the upper limb in breast cancer patients with negative sentinel node: a prospective randomised study [in Spanish].  Cir Esp. 2011;89(5):307-316
5. Fleissig A, Fallowfield LJ, Langridge CI,  et al.  Post-operative arm morbidity and quality of life: results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer.  Breast Cancer Res Treat. 2006;95(3):279-293
6. Lucci A, McCall LM, Beitsch PD,  et al; American College of Surgeons Oncology Group.  Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.  J Clin Oncol. 2007;25(24):3657-3663
7. Ashikaga T, Krag DN, Land SR,  et al; National Surgical Adjuvant Breast, Bowel Project.  Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection vs axillary dissection.  J Surg Oncol. 2010;102(2):111-118

8. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL. Improved axillary staging of breast cancer with sentinel lymphadenectomy.  Ann Surg. 1995;222(3):394-401
9. Cote RJ, Peterson HF, Chaiwun B,  et al; International Breast Cancer Study Group.  Role of immunohistochemical detection of lymph-node metastases in management of breast cancer.  Lancet. 1999;354(9182):896-900
10. van der Heiden-van der Loo M, Bezemer PD, Hennipman A,  et al.  Introduction of sentinel node biopsy and stage migration of breast cancer.  Eur J Surg Oncol. 2006;32(7):710-714
11. Hansen NM, Grube B, Ye X,  et al.  Impact of micrometastases in the sentinel node of patients with invasive breast cancer.  J Clin Oncol. 2009;27(28):4679-4684
12. Giuliano AE, Hawes D, Ballman KV,  et al.  Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer.  JAMA. 2011;306(4):385-393
13. Weaver DL, Ashikaga T, Krag DN,  et al.  Effect of occult metastases on survival in node-negative breast cancer.  N Engl J Med. 2011;364(5):412-421
14. Takeshita T, Tsuda H, Moriya T,  et al.  Clinical implications of occult metastases and isolated tumor cells in sentinel and non-sentinel lymph nodes in early breast cancer patients: serial step section analysis with long-term follow-up.  Ann Surg Oncol. 2012;19(4):1160-1166
15. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer.  Ann Surg. 1994;220(3):391-401
16. Turner RR, Ollila DW, Krasne DL, Giuliano AE. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma.  Ann Surg. 1997;226(3):271-278
17. Edge SE. Breast cancer. In: Edge SE, Byrd DR, Compton C, et al, eds. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2009
18. Darby S, McGale P, Correa C,  et al; Early Breast Cancer Trialists' Collaborative Group (EBCTCG).  Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials.  Lancet. 2011;378(9804):1707-1716
19. Wernicke AG, Goodman RL, Turner BC,  et al.  A 10-year follow-up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance.  Breast Cancer Res Treat. 2011;125(3):893-902